News & Press
NRFC invests AUD $54 million in Synchron's groundbreaking brain-computer interface devices
NRF Australia11/7/2025·11/07/25🌐 Australia
Summary
The Australian National Reconstruction Fund Corporation (NRFC) invested AUD $54 million in Synchron, a company developing implantable BCI devices. Synchron's stentrode technology is inserted via blood vessels without open brain surgery, offering a less invasive approach to BCI implantation. The investment supports Australia's strategic position in the global neurotechnology sector.
Why it matters
This major Australian government-backed investment in Synchron signals strong institutional support for BCI technology in the Asia-Pacific region. Synchron's vascular approach to BCI could prove safer and more scalable than traditional invasive methods.
#BCI#Neural Interfaces#Australia#Venture Capital#Industry
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in